CompanyNews

EmpowerPharm Inc. is delighted to announce the outcome of their Phase 2 clinical trial assessing Cannabidiol (CBD) drug product for Social Anxiety Disorder (SAD)

EmpowerPharm Inc. https://empowerpharm.ca/ is delighted to announce the outcome of their Phase 2 clinical trial assessing the dose finding, efficacy, safety, and tolerability of Cannabidiol (CBD) drug product for Social Anxiety Disorder (SAD). The results demonstrated efficacy for a subset of patients suffering from moderate to severe SAD.

Read More »

EmpowerPharm Inc. welcomes Terri-Jean (TJ) Geddis

TJ is a commercial leader with over 25 years of experience in both the pharmaceutical and biotech industries. She started her career at larger companies such as Eli Lilly and with her entrepreneurial mindset, gravitated to smaller, Canadian start-up organizations such as Alexion and Mitsubishi Tanabe Pharma.

Read More »

EmpowerPharm Inc. welcomes Chirag Shah

EmpowerPharm is delighted to announce the appointment of Mr. Chirag Shah who will join our Company as our Vice President Pharmaceutical Development on June 21st. Chirag will lead our development initiatives.

Read More »